합성생물학 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Synthetic Biology Market size is expected to reach USD 84.31 Billion in 2034 from USD 19.29 Billion (2025) growing at a CAGR of 17.81% during 2026-2034.

The Global Synthetic Biology market has expanded significantly due to advancements in genetic engineering and biotechnology. Synthetic biology enables the design of customized biological systems for healthcare, agriculture, and industrial applications. Increasing research investments and demand for innovative therapies have supported rapid market growth. Expanding bio-based product development further strengthens industry expansion.

Growth drivers include rising demand for gene editing technologies and bio-manufacturing solutions. Applications in vaccine development and renewable chemicals contribute to steady demand. Collaboration between research institutions and biotechnology companies accelerates innovation. Additionally, supportive government funding enhances research activities.

Future prospects remain highly promising as breakthroughs in genome editing continue. Development of sustainable bio-based materials and fuels will create new opportunities. Integration of artificial intelligence in biological design will enhance efficiency. The market is projected to grow robustly alongside scientific advancements.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Oligonucleotide/Oligo Pools And Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Xeno-Nucleic Acids
• Chassis Organism

By Technology

• Ngs Technology
• Pcr Technology
• Genome Editing Technology
• Bioprocessing Technology
• Other Technologies

By Application

• Healthcare
• Non-Healthcare

By End Use

• Biotechnology And Pharmaceutical Companies
• Academic And Research Institutes
• Others

COMPANIES PROFILED

• Bota Biosciences Inc, Codexis Inc, Creative Biogene, Creative Enzymes, Enbiotix Inc, Illumina Inc, Merck KGaA SigmaAldrich Co LLC, New England Biolabs, Eurofins Scientific, Novozymes, Pareto Bio Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SYNTHETIC BIOLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Oligonucleotide/Oligo Pools And Synthetic DNA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cloning Technologies Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Xeno-Nucleic Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Chassis Organism Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SYNTHETIC BIOLOGY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Ngs Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pcr Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Genome Editing Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Bioprocessing Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SYNTHETIC BIOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Non-Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SYNTHETIC BIOLOGY MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Biotechnology And Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SYNTHETIC BIOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SYNTHETIC BIOLOGY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Bota Biosciences Inc
  • 10.2.2 Codexis Inc
  • 10.2.3 Creative Biogene
  • 10.2.4 Creative Enzymes
  • 10.2.5 Enbiotix Inc
  • 10.2.6 Illumina Inc
  • 10.2.7 Merck KGaA (Sigma-Aldrich Co. LLC)
  • 10.2.8 New England Biolabs
  • 10.2.9 Eurofins Scientific
  • 10.2.10 Novozymes
  • 10.2.11 Pareto Bio Inc